Viramune
Viramune is designed to target HIV to mitigate viral replication, utilized to support immune system function and to address long-term viral progression.
Strengths: 200mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
- Pharmacological class
NNRTI
- Contraindications
severe hepatic impairment; hypersensitivity to nevirapine
- Minor side effects
nausea; headache; fatigue; rash
- Moderate side effects
elevated liver enzymes; vomiting
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Boehringer Ingelheim
- Onset Time
1–4 hours
- Duration
24 hours
- Storage instructions
Store at room temperature.
- Drug interactions
rifampicin; hormonal contraceptives; st. john's wort; warfarin
- Age restrictions
For adults and children as directed.
Precautions and warnings
monitor liver function closely; watch for signs of severe skin rash; regular blood monitoring required
Serious side effects
stevens-johnson syndrome — requires immediate medical attention; hepatitis — requires immediate medical attention
Patient summary
Viramune is designed to target HIV to mitigate viral replication, utilized to support immune system function and to address long-term viral progression.
Mechanism of action
Viramune functions as a non-nucleoside reverse transcriptase inhibitor. It binds directly to the reverse transcriptase enzyme of HIV-1, preventing the conversion of viral RNA into DNA, which effectively stops the virus from replicating.
Pregnancy and breastfeeding
Pregnancy: Use only if clearly indicated by a specialist. Breastfeeding: Not advised due to risk of virus transmission.
Viramune
Viramune is designed to target HIV to mitigate viral replication, utilized to support immune system function and to address long-term viral progression.
Editorial Notes
- Active ingredient(s): Nevirapine
- Listed indication(s): HIV Infection
Available option
- 30 tablets - 200 mg703-200-mg-1594